My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
January 2014
Policy and Advocacy
IDSA Supports Diagnostics Bill Moving through House of Representatives
Congress is considering legislation that would increase patient access to important diagnostic testing services by helping to ensure appropriate reimbursement. IDSA members can help garner support for the bill by using IDSA’s Action Alert to urge congressional Representatives to co-sponsor it.
 
In a letter to Rep. Peter Roskam (R- IL), IDSA President Barbara Murray, MD, FIDSA, expressed the Society’s support for the bill, known as the Diagnostic Innovation Testing and Knowledge Advancement Act, which he introduced last year.   
 
Medicare’s appropriate valuation of diagnostic tests is needed to spur innovation and integration into clinical care. The letter explained that diagnostic tests help guide and improve patient care, and that their appropriate use can improve patient outcomes and reduce health care costs associated with suboptimal treatment. IDSA also expressed its strong support of a provision in the bill that would establish an independent advisory panel to provide expert input into rate setting and consideration of patient value and potential impact on health as criteria for use in a new payment setting process.
 
IDSA’s work on this legislation is one of several current efforts to promote improved diagnostics, a high priority for the Society. Last November, IDSA released “Better Tests, Better Care: Improved Diagnostics for Infectious Diseases,” a special policy report in Clinical Infectious Diseases, which outlined specific recommendations to spur the development of new diagnostics and encourage their use in patient care and public health. 


< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
FDA Approves Simeprevir and Sofosbuvir for Chronic Hepatitis C
Policy and Advocacy
Congress Approves Partial Relief from Sequestration Funding Cuts
IDSA Supports Diagnostics Bill Moving through House of Representatives
IDSA and PIDS Submit Comments to FDA on Proposed Drug Shortage Rule
Congressional Briefing Highlights Barriers to Immunization for Older Adults
IDSA, SHEA, PIDS Call for Mandatory Immunization of Health Care Personnel
HIVMA Welcomes HIV Policy Assessment Directive in Defense Bill
President Obama Mentions Vaccines and Drug Resistance in State of the Union
Clinical Practice Management
New Resource Helps ID Specialists Prove Their Value
President Obama Signs Bill to Prevent Scheduled Medicare Cut
Science Speaks Blog
The Center for Global Health Policy Examines the Impact of Drug Prices on Vulnerable Populations, and Other Newsworthy Events
You and Your Colleagues
Renew Dues and Update Your Membership
Members on the Move
New Members
In Memoriam: Martin C. McHenry, MD, MS, FIDSA (1932-2013)
Education and Resources
Free Online Course on Antimicrobial Stewardship
Changes to ABIM MOC Now In Effect
Open Forum Infectious Diseases Now Accepting Submissions
Apply Now for the ID Research Careers Meeting
Top Story
From the President: New Website Provides Clinicians with Timely Advice on HCV
ADAPT Act Would Promote New Drug Development
Updated Guideline for Vaccination of Immunocompromised Host Now Available
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.